Annual CFF
$5.96 M
+$4.09 M+219.30%
December 1, 2023
Summary
- As of February 12, 2025, ZVSA annual cash flow from financing activities is $5.96 million, with the most recent change of +$4.09 million (+219.30%) on December 1, 2023.
- During the last 3 years, ZVSA annual CFF has risen by +$1.40 million (+30.62%).
- ZVSA annual CFF is now at all-time high.
Performance
ZVSA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$647.80 K
+$647.80 K+100.00%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA quarterly cash flow from financing activities is $647.80 thousand, with the most recent change of +$647.80 thousand (+100.00%) on September 1, 2024.
- Over the past year, ZVSA quarterly CFF has dropped by -$2.02 million (-75.76%).
- ZVSA quarterly CFF is now -85.10% below its all-time high of $4.35 million, reached on December 1, 2023.
Performance
ZVSA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$7.67 M
-$1.64 M-17.61%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA TTM cash flow from financing activities is $7.67 million, with the most recent change of -$1.64 million (-17.61%) on September 1, 2024.
- Over the past year, ZVSA TTM CFF has dropped by -$996.80 thousand (-11.51%).
- ZVSA TTM CFF is now -17.61% below its all-time high of $9.31 million, reached on June 1, 2024.
Performance
ZVSA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ZVSA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +219.3% | -75.8% | -11.5% |
| 3 y3 years | +30.6% | +118.6% | +1011.6% |
| 5 y5 years | +30.6% | +118.6% | +1011.6% |
ZVSA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +219.3% | -85.1% | +200.9% | -17.6% | +1849.3% |
| 5 y | 5-year | at high | +219.3% | -85.1% | +200.9% | -17.6% | +1849.3% |
| alltime | all time | at high | +219.3% | -85.1% | +200.9% | -17.6% | +1849.3% |
ZyVersa Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $647.80 K(>+9900.0%) | $7.67 M(-17.6%) |
| Jun 2024 | - | $0.00(-100.0%) | $9.31 M(+7.4%) |
| Mar 2024 | - | $2.67 M(-38.5%) | $8.66 M(+45.5%) |
| Dec 2023 | $5.96 M | $4.35 M(+90.1%) | $5.96 M(+180.6%) |
| Sep 2023 | - | $2.29 M(-456.2%) | $2.12 M(+325.2%) |
| Jun 2023 | - | -$641.80 K(+1749.6%) | $499.20 K(-65.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$34.70 K(-106.8%) | $1.44 M(-22.9%) |
| Dec 2022 | $1.87 M(-64.3%) | $512.90 K(-22.6%) | $1.87 M(+37.9%) |
| Sep 2022 | - | $662.80 K(+123.6%) | $1.35 M(+96.1%) |
| Jun 2022 | - | $296.40 K(-24.6%) | $689.70 K(+75.4%) |
| Mar 2022 | - | $393.30 K | $393.30 K |
| Dec 2021 | $5.23 M(+14.7%) | - | - |
| Dec 2020 | $4.56 M | - | - |
FAQ
- What is ZyVersa Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual CFF year-on-year change?
- What is ZyVersa Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly CFF year-on-year change?
- What is ZyVersa Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics TTM CFF year-on-year change?
What is ZyVersa Therapeutics annual cash flow from financing activities?
The current annual CFF of ZVSA is $5.96 M
What is the all time high annual CFF for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual cash flow from financing activities is $5.96 M
What is ZyVersa Therapeutics annual CFF year-on-year change?
Over the past year, ZVSA annual cash flow from financing activities has changed by +$4.09 M (+219.30%)
What is ZyVersa Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ZVSA is $647.80 K
What is the all time high quarterly CFF for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly cash flow from financing activities is $4.35 M
What is ZyVersa Therapeutics quarterly CFF year-on-year change?
Over the past year, ZVSA quarterly cash flow from financing activities has changed by -$2.02 M (-75.76%)
What is ZyVersa Therapeutics TTM cash flow from financing activities?
The current TTM CFF of ZVSA is $7.67 M
What is the all time high TTM CFF for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high TTM cash flow from financing activities is $9.31 M
What is ZyVersa Therapeutics TTM CFF year-on-year change?
Over the past year, ZVSA TTM cash flow from financing activities has changed by -$996.80 K (-11.51%)